Keyword: Tim Anderson


New Novartis meds help relieve Gleevec generics pain

It’s accentuate-the-positive time at Novartis. The Swiss drugmaker’s sales and earnings suffered in the first quarter, thanks to an early generic version of blockbuster leukemia drug Gleevec. But as the company was quick to point out, growth in newer products helped pick up the slack.